Patterns of Care Survey for Acute Myeloid Leukemia (AML)

Five-Day Decitabine Therapy for Elderly Patients with Acute Myeloid Leukemia (AML)

CIBMTR Analysis of HCT in Older Patients with AML or MDS

New Prognostic Markers in Acute Myeloid Leukemia (AML)

Phase II Study of Clofarabine for Older Patients with Treatment-Naïve AML

A Prognostic Model for MDS that Accounts for Events Not Considered by the International Prognostic Scoring System (IPSS)

Three Alternate Dosing Schedules of Azacitidine for MDS

EORTC-06011: Low-Dose Decitabine versus Best Supportive Care for Elderly Patients with Intermediate- or High-Risk MDS

Myelodysplastic Syndromes

Azacitidine Before Allogeneic Hematopoietic Cell Transplantation (AHCT) for Myelodysplasias

Anthracycline Dose Intensification in Acute Myeloid Leukemia (AML)

Outcome of Myelodysplastic Syndrome (MDS) with and without
Chromosome 5 Abnormalities

Efficacy of Azacitidine in Higher-Risk Myelodysplastic Syndrome (MDS)

Cooked and Noncooked Diets in Patients with Acute Myeloid Leukemia (AML) Undergoing Remission Induction Therapy

Pazopanib in Patients with Treatment-Naïve or Cytokine-Pretreated Advanced RCC